Outcome Of Treatment Of Prostate Cancer at Sohag University Hospital Between 2017 to 2021

Sohag University

Status: Unknown

Conditions: Prostate Cancer

Treatments: Radiation: external beam radiotherapy; Drug: androgen deprivation therapy

Study type: Observational

Funder types: Other

Identifiers

NCT05382182

Soh-Med-22-05-03

Details and patient eligibility

About

Worldwide, prostate cancer is the most commonly diagnosed male cancer and the fourth leading cause of cancer death in men. Risk stratification is according to cancer stage, Gleason score, and PSA level .

Definitive treatment of localized disease ( low and favorable intermediate risk) includes watchful waiting , active surveillance , radiation therapy , radical prostatectomy and cryotherapy .Primary treatment of unfavorable intermediate risk , high risk localized disease and locally advanced prostate cancer , includes both radical prostatectomy (RP) and EBRT + long-term androgen deprivation therapy (ADT) .Treatment options of metastatic prostate cancer include pain medications, bisphosphonates, hormonal treatment, chemotherapy, radiotherapy, immunotherapy, focused radiation, and other targeted therapies .

Enrollment: 100 estimated patients

Sex: Male

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients at age of 18 years old and above.
• All stages and grades of prostate cancer.
• Epithelial types of prostate cancer.

Exclusion criteria

• Age below 18 years old.
• Presence of other malignancies.